Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3399507 | 0.92 | MEN1 (0.33) | MEN1KMT2AHTTL3MBTL1LMNA | |
| SCHEMBL3397667 | 0.83 | MEN1 (0.34) | MEN1KMT2AHTTL3MBTL1LMNA | |
| SCHEMBL15263236 | 0.82 | FFAR1 (0.38) | MEN1KMT2AHTTL3MBTL1LMNA | |
| SCHEMBL11060568 | 0.82 | FFAR1 (0.38) | MEN1KMT2AHTTL3MBTL1LMNA | |
| SCHEMBL2174381 | 0.80 | CHRM2 (0.41) | MEN1KMT2ALMNAALDH1A1 | |
| SCHEMBL1149044 | 0.80 | MEN1 (0.31) | MEN1KMT2AHTTL3MBTL1LMNA | |
| SCHEMBL22321638 | 0.80 | MEN1 (0.31) | MEN1KMT2AHTTL3MBTL1 | |
| SCHEMBL2121005 | 0.80 | CHRM2 (0.41) | MEN1KMT2ALMNAALDH1A1 | |
| SCHEMBL16401965 | 0.80 | MEN1 (0.31) | MEN1KMT2AHTTL3MBTL1LMNA | |
| SCHEMBL2125590 | 0.80 | CHRM2 (0.41) | MEN1KMT2ALMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120107248-A1 | IMAGING GASTROINTESTINAL VOLUMES AND MOTILITY | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2012-05-03 | — | — | US | disclosed |
| WO-2011005609-A2 | IMAGING GASTROINTESTINAL VOLUMES AND MOTILITY | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2011-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120107248-A1 | IMAGING GASTROINTESTINAL VOLUMES AND MOTILITY | SLC10A2, KCNN3, KCNN2 | MEN1 1222/4885KMT2A 1714/4885HTT 571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.